Skip to main content
. 2019 Jul 5;105(1):201–208. doi: 10.3324/haematol.2019.219295

Figure 1.

Figure 1.

Overall survival (OS) estimates comparing patients with extramedullary plasmacytomas (EMP) to those with paraosseous (PO) lesions (A) at diagnosis and (B) at relapse. EMD: extramedullary disease.